Regulation of nephron water and electrolyte transport by adenylyl cyclases

American Journal of Physiology - Renal Physiology

Volumn 306, Issue 7, 2014, Pages

  Rieg, Timo ^a,b   Kohan, Donald E ^c,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Homeostasis; Parathyroid hormone; Renal disease; Signaling; Vasopressin

Indexed keywords

ADENYLATE CYCLASE; ARGIPRESSIN; CALCITONIN; CYCLIC AMP; DOPAMINE; FORSKOLIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; ISOPRENALINE; MESSENGER RNA; MOZAVAPTAN; PARATHYROID HORMONE; SODIUM ION; TOLVAPTAN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

CONFOCAL LASER MICROSCOPY; DISEASE COURSE; ELECTROLYTE TRANSPORT; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HENLE LOOP; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY COLLECTING TUBULE; KIDNEY CORTEX; KIDNEY DISEASE; KIDNEY DISTAL TUBULE; KIDNEY FUNCTION; KIDNEY MEDULLA; KIDNEY POLYCYSTIC DISEASE; KIDNEY PROXIMAL TUBULE; MACULA DENSA; NEPHRON; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SODIUM EXCRETION; URINARY EXCRETION; WATER TRANSPORT;

HOMEOSTASIS; PARATHYROID HORMONE; RENAL DISEASE; SIGNALING; VASOPRESSIN;

ADENYLATE CYCLASE; ANIMALS; BIOLOGICAL TRANSPORT; CYCLIC AMP; ENZYME ACTIVATION; HUMANS; ISOENZYMES; KIDNEY DISEASES; NEPHRONS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; WATER-ELECTROLYTE BALANCE;

EID: 84900541584     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00656.2013     Document Type: Review

References (91)

1. Anonymous. http://www.fda.gov/Drugs/DrugSafety/ucm350062.htm.
2. Aldehni F, Tang T, Madsen K, Plattner M, Schreiber A, Friis UG, Hammond HK, Han PL, Schweda F. Stimulation of renin secretion by catecholamines is dependent on adenylyl cyclases 5 and 6. Hypertension 57: 460-468, 2011.
3. Antoni FA. New paradigms in cAMP signalling. Mol Cell Endocrinol 353: 3-9, 2012.
4. Atchison DK, Harding P, Cecilia Ortiz-Capisano M, Peterson EL, and Beierwaltes WH. Parathyroid hormone stimulates juxtaglomerular cell cAMP accumulation without stimulating renin release. Am J Physiol Renal Physiol 303: F1157-F1165, 2012.
5. Bailly C, Imbert-Teboul M, Chabardes D, Hus-Citharel A, Montegut M, Clique A, Morel F. The distal nephron of rat kidney: a target site for glucagon. Proc Natl Acad Sci USA 77: 3422-3424, 1980.
6. Beazely MA, Watts VJ. Regulatory properties of adenylate cyclases type 5 and 6: a progress report. Eur J Pharmacol 535: 1-12, 2006.
7. Bek MJ, Zheng S, Xu J, Yamaguchi I, Asico LD, Sun XG, Jose PA. Differential expression of adenylyl cyclases in the rat nephron. Kidney Int 60: 890-899, 2001.
8. Breyer MD, Breyer RM. G protein-coupled prostanoid receptors and the kidney. Annu Rev Physiol 63: 579-605, 2001.
9. + channel in the collecting duct by vasopressin contributes to water reabsorption. Am J Physiol Renal Physiol 297: F1411-F1418, 2009.
10. - cotransporter NKCC2 in the thick ascending limb: role of protein kinase A. J Biol Chem 284: 24965-24971, 2009.
11. + exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells. Am J Physiol Renal Physiol 297: F1647-F1655, 2009.
12. 2+-inhibitable adenylyl cyclases along the renal tubule. Functional consequences for regulation of the cAMP content. J Biol Chem 271: 19264-19271, 1996.
13. Chabardes D, Gagnan-Brunette M, Imbert-Teboul M, Gontcharevskaia O, Montegut M, Clique A, Morel F. Adenylate cyclase responsiveness to hormones in various portions of the human nephron. J Clin Invest 65: 439-448, 1980.
14. Chabardes D, Imbert M, Clique A, Montegut M, Morel F. PTH sensitive adenyl cyclase activity in different segments of the rabbit nephron. Pflügers Arch 354: 229-239, 1975.
15. Chabardes D, Imbert-Teboul M, Gagnan-Brunette M, Morel F. Different hormonal target sites along the mouse and rabbit nephrons. Curr Probl Clin Biochem 8: 447-454, 1977.
16. Chabardes D, Imbert-Teboul M, Montegut M, Clique A, Morel F. Catecholamine sensitive adenylate cyclase activity in different segments of the rabbit nephron. Pflügers Arch 361: 9-15, 1975.
17. Chabardes D, Imbert-Teboul M, Montegut M, Clique A, Morel F. Distribution of calcitonin-sensitive adenylate cyclase activity along the rabbit kidney tubule. Proc Natl Acad Sci USA 73: 3608-3612, 1976.
18. Chien CL, Wu YS, Lai HL, Chen YH, Jiang ST, Shih CM, Lin SS, Chang C, Chern Y. Impaired water reabsorption in mice deficient in the type VI adenylyl cyclase (AC6). FEBS Lett 584: 2883-2890, 2010.
19. Crajoinas RO, Oricchio FT, Pessoa TD, Pacheco BP, Lessa LM, Malnic G, Girardi AC. Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1. Am J Physiol Renal Physiol 301: F355-F363, 2011.
20. de Rouffignac C, Corman B, Roinel N. Stimulation by antidiuretic hormone of electrolyte tubular reabsorption in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 244: F156-F164, 1983.
21. Dessauer CW. Adenylyl cyclase-A-kinase anchoring protein complexes: the next dimension in cAMP signaling. Mol Pharmacol 76: 935-941, 2009.
22. Edwards HV, Christian F, Baillie GS. CAMP: novel concepts in compartmentalised signalling. Semin Cell Dev Biol 23: 181-190, 2012.
23. Elalouf JM, Roinel N, de Rouffignac C. Effects of antidiuretic hormone on electrolyte reabsorption and secretion in distal tubules of rat kidney. Pflügers Arch 401: 167-173, 1984.
24. Erdorf M, Seifert R. Pharmacological characterization of adenylyl cyclase isoforms in rabbit kidney membranes. Naunyn Schmiedebergs Arch Pharmacol 383: 357-372, 2011.
25. Fenton RA, Pedersen CN, Moeller HB. New insights into regulated aquaporin-2 function. Curr Opin Nephrol Hypertens 22: 551-558, 2013.
26. Forte LR. Activation of renal adenylate cyclase by forskolin: assessment of enzymatic activity in animal models of the secondary hyperparathyroid state. Arch Biochem Biophys 225: 898-905, 1983.
27. Forte LR, Nickols GA, Anast CS. Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion. J Clin Invest 57: 559-568, 1976.
28. Gattone VH, Wang X, Harris PC, Torres VE. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 9: 1323-1326, 2003.
29. Gimenez I, Forbush B. Regulatory phosphorylation sites in the NH2 terminus of the renal Na-K-Cl cotransporter (NKCC2). Am J Physiol Renal Physiol 289: F1341-F1345, 2005.
30. Griffiths NM, Brick-Ghannam C, Siaume-Perez S, Chabardes D. Effect of prostaglandin E2 on agonist-stimulated cAMP accumulation in the distal convoluted tubule isolated from the rabbit kidney. Pflügers Arch 422: 577-584, 1993.
31. Griffiths NM, Chabardes D, Imbert-Teboul M, Siaume-Perez S, Morel F, Simmons NL. Distribution of vasoactive intestinal peptide-sensitive adenylate cyclase activity along the rabbit nephron. Pflügers Arch 412: 363-368, 1988.
32. Gunaratne R, Braucht DW, Rinschen MM, Chou CL, Hoffert JD, Pisitkun T, Knepper MA. Quantitative phosphoproteomic analysis reveals cAMP/vasopressin-dependent signaling pathways in native renal thick ascending limb cells. Proc Natl Acad Sci USA 107: 15653-15658, 2010.
33. Hallows KR, Wang H, Edinger RS, Butterworth MB, Oyster NM, Li H, Buck J, Levin LR, Johnson JP, Pastor-Soler NM. Regulation of epithelial Na_ transport by soluble adenylyl cyclase in kidney collecting duct cells. J Biol Chem 284: 5774-5783, 2009.
34. 2+-signaling pathways of adenylyl cyclases. Cold Spring Harb Perspect Biol 3: a004143, 2011.
35. Harris PC. 2008 Homer W. Smith Award: insights into the pathogenesis of polycystic kidney disease from gene discovery. J Am Soc Nephrol 20: 1188-1198, 2009.
36. Helies-Toussaint C, Aarab L, Gasc JM, Verbavatz JM, Chabardes D. Cellular localization of type 5 and type 6 ACs in collecting duct and regulation of cAMP synthesis. Am J Physiol Renal Physiol 279: F185-F194, 2000.
37. Higashihara E, Torres VE, Chapman AB, Grantham JJ, Bae K, Watnick TJ, Horie S, Nutahara K, Ouyang J, Krasa HB, Czerwiec FS. Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience. Clin J Am Soc Nephrol 6: 2499-2507, 2011.
38. Hoffert JD, Chou CL, Fenton RA, Knepper MA. Calmodulin is required for vasopressin-stimulated increase in cyclic AMP production in inner medullary collecting duct. J Biol Chem 280: 13624-13630, 2005.
39. Hoffert JD, Fenton RA, Moeller HB, Simons B, Tchapyjnikov D, McDill BW, Yu MJ, Pisitkun T, Chen F, Knepper MA. Vasopressinstimulated increase in phosphorylation at Ser269 potentiates plasma membrane retention of aquaporin-2. J Biol Chem 283: 24617-24627, 2008.
40. Hoffert JD, Pisitkun T, Wang G, Shen RF, Knepper MA. Quantitative phosphoproteomics of vasopressin-sensitive renal cells: regulation of aquaporin-2 phosphorylation at two sites. Proc Natl Acad Sci USA 103: 7159-7164, 2006.
41. Imbert M, Chabardes D, Montegut M, Clique A, Morel F. Vasopressin dependent adenylate cyclase in single segments of rabbit kidney tubule. Pflügers Arch 357: 173-186, 1975.
42. Kaminsky NI, Broadus AE, Hardman JG, Jones DJ Jr, Ball JH, Sutherland EW, Liddle GW. Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man. J Clin Invest 49: 2387-2395, 1970.
43. Kittikulsuth W, Stuart D, Van Hoek AN, Stockand JD, Bugaj V, Mironova E, Blount MA, Kohan DE. Lack of an effect of collecting duct-specific deletion of adenylyl cyclase 3 on renal sodium and water excretion or arterial pressure. Am J Physiol Renal Physiol (First published January 15, 2014). doi:10.1152/ajprenal.00505.2013.
44. Knox FG, Preiss J, Kim JK, Dousa TP. Mechanism of resistance to the phosphaturic effect of the parathyroid hormone in the hamster. J Clin Invest 59: 675-683, 1977.
45. Laroche-Joubert N, Marsy S, Michelet S, Imbert-Teboul M, Doucet A. Protein kinase A-independent activation of ERK and H,K-ATPase by cAMP in native kidney cells: role of Epac I. J Biol Chem 277: 18598-18604, 2002.
46. Linder JU. Class III adenylyl cyclases: molecular mechanisms of catalysis and regulation. Cell Mol Life Sci 63: 1736-1751, 2006.
47. Maeda A, Okazaki M, Baron DM, Dean T, Khatri A, Mahon M, Segawa H, bou-Samra AB, Juppner H, Bloch KD, Potts JT Jr, Gardella TJ. Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH. Proc Natl Acad Sci USA 110: 5864-5869, 2013.
48. Martin KJ, Stokes TJ Jr, McConkey CL Jr. Influence of forskolin on the parathyroid hormone dependent adenylate cyclase system of canine kidney: evidence for noncatalytic effects of forskolin. Endocrinology 115: 1678-1682, 1984.
49. Moeller HB, Fenton RA. Cell biology of vasopressin-regulated aquaporin- 2 trafficking. Pflügers Arch 464: 133-144, 2012.
50. Morath R, Klein T, Seyberth HW, Nusing RM. Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney. J Am Soc Nephrol 10: 1851-1860, 1999.
51. - cotransporter by vasopressin involves phosphorylation and membrane translocation. Am J Physiol Renal Physiol 298: F502-F509, 2010.
52. Nicco C, Wittner M, DiStefano A, Jounier S, Bankir L, Bouby N. Chronic exposure to vasopressin upregulates ENaC and sodium transport in the rat renal collecting duct and lung. Hypertension 38: 1143-1149, 2001.
53. Ortiz-Capisano MC, Ortiz PA, Harding P, Garvin JL, Beierwaltes WH. Adenylyl cyclase isoform v mediates renin release from juxtaglomerular cells. Hypertension 49: 618-624, 2007.
54. Pastor-Soler N, Beaulieu V, Litvin TN, Da SN, Chen Y, Brown D, Buck J, Levin LR, Breton S. Bicarbonate-regulated adenylyl cyclase (sAC) is a sensor that regulates pH-dependent V-ATPase recycling. J Biol Chem 278: 49523-49529, 2003.
55. Paunescu TG, Da SN, Russo LM, McKee M, Lu HA, Breton S, Brown D. Association of soluble adenylyl cyclase with the V-ATPase in renal epithelial cells. Am J Physiol Renal Physiol 294: F130-F138, 2008.
56. Pedersen NB, Hofmeister MV, Rosenbaek LL, Nielsen J, Fenton RA. Vasopressin induces phosphorylation of the thiazide-sensitive sodium chloride cotransporter in the distal convoluted tubule. Kidney Int 78: 160-169, 2010.
57. Pierre S, Eschenhagen T, Geisslinger G, Scholich K. Capturing adenylyl cyclases as potential drug targets. Nat Rev Drug Discov 8: 321-335, 2009.
58. Pines M, Polin D, Hurwitz S. Urinary cyclic AMP excretion in birds: dependence on parathyroid hormone activity. Gen Comp Endocrinol 49: 90-96, 1983.
59. Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, Brunet I, Wan LX, Rey F, Wang T, Firestein SJ, Yanagisawa M, Gordon JI, Eichmann A, Peti-Peterdi J, Caplan MJ. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci USA 110: 4410-4415, 2013.
60. Pluznick JL, Zou DJ, Zhang X, Yan Q, Rodriguez-Gil DJ, Eisner C, Wells E, Greer CA, Wang T, Firestein S, Schnermann J, Caplan MJ. Functional expression of the olfactory signaling system in the kidney. Proc Natl Acad Sci USA 106: 2059-2064, 2009.
61. Rees S, Kittikulsuth W, Roos K, Strait KA, Van HA, Kohan DE. Adenylyl cyclase 6 deficiency ameliorates polycystic kidney disease. J Am Soc Nephrol 25: 232-237, 2014.
62. Ricci A, Collier WL, Rossodivita I, Amenta F. Dopamine receptors mediating inhibition of the cyclic adenosine monophosphate generating system in the rat renal cortex. J Auton Pharmacol 11: 121-127, 1991.
63. Rieg T, Gerasimova M, Murray F, Masuda T, Tang T, Rose M, Drucker DJ, Vallon V. Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice. Am J Physiol Renal Physiol 303: F963-F971, 2012.
64. Rieg T, Sharik M, Tang T, Aroonsakool A, Murray F. PTH-stimulated urinary phosphate and cAMP excretion are absent in mice lacking adenylyl cyclase 6. FASEB J 27: A1210.14, 2013.
65. Rieg T, Tang T, Murray F, Schroth J, Insel PA, Fenton RA, Hammond HK, Vallon V. Adenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla. J Am Soc Nephrol 21: 2059-2068, 2010.
66. Rieg T, Tang T, Uchida S, Hammond HK, Fenton RA, Vallon V. Adenylyl cyclase 6 enhances NKCC2 expression and mediates vasopressin- induced phosphorylation of NKCC2 and NCC. Am J Pathol 182: 96-106, 2013.
67. Roos KP, Bugaj V, Mironova E, Stockand JD, Ramkumar N, Rees S, Kohan DE. Adenylyl cyclase VI mediates vasopressin-stimulated ENaC activity. J Am Soc Nephrol 24: 218-227, 2013.
68. Roos KP, Strait KA, Raphael KL, Blount MA, Kohan DE. Collecting duct-specific knockout of adenylyl cyclase type VI causes a urinary concentration defect in mice. Am J Physiol Renal Physiol 302: F78-F84, 2012.
69. Rosenbaek LL, Assentoft M, Pedersen NB, MacAulay N, Fenton RA. Characterization of a novel phosphorylation site in the sodium-chloride cotransporter, NCC. J Physiol 590: 6121-6139, 2012.
70. Sadana R, Dessauer CW. Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies. Neurosignals 17: 5-22, 2009.
71. Saritas T, Borschewski A, McCormick JA, Paliege A, Dathe C, Uchida S, Terker A, Himmerkus N, Bleich M, Demaretz S, Laghmani K, Delpire E, Ellison DH, Bachmann S, Mutig K. SPAK differentially mediates vasopressin effects on sodium cotransporters. J Am Soc Nephrol 24: 407-418, 2013.
72. Sasaki S, Imai M. Effects of vasopressin on water and NaCl transport across the in vitro perfused medullary thick ascending limb of Henle's loop of mouse, rat, and rabbit kidneys. Pflügers Arch 383: 215-221, 1980.
73. Schmidt M, Dekker FJ, Maarsingh H. Exchange protein directly activated by cAMP (epac): a multidomain cAMP mediator in the regulation of diverse biological functions. Pharmacol Rev 65: 670-709, 2013.
74. Schoeppe W. Effects of dopamine on kidney function. Proc R Soc Med 70, Suppl 2: 36-42, 1977.
75. Seamon KB, Padgett W, Daly JW. Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci USA 78: 3363-3367, 1981.
76. Seifert R, Lushington GH, Mou TC, Gille A, Sprang SR. Inhibitors of membranous adenylyl cyclases. Trends Pharmacol Sci 33: 64-78, 2012.
77. Shen T, Suzuki Y, Poyard M, Miyamoto N, Defer N, Hanoune J. Expression of adenylyl cyclase mRNAs in the adult, in developing, and in the Brattleboro rat kidney. Am J Physiol Cell Physiol 273: C323-C330, 1997.
78. Slatopolsky E, Mercado A, Morrison A, Yates J, Klahr S. Inhibitory effects of hypermagnesemia on the renal action of parathyroid hormone. J Clin Invest 58: 1273-1279, 1976.
79. Strait KA, Stricklett PK, Chapman M, Kohan DE. Characterization of vasopressin-responsive collecting duct adenylyl cyclases in the mouse. Am J Physiol Renal Physiol 298: F859-F867, 2010.
80. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367: 2407-2418, 2012.
81. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 369: 1287-1301, 2007.
82. Torres VE, Meijer E, Bae KT, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang JJ, Czerwiec FS. Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study. Am J Kidney Dis 57: 692-699, 2011.
83. Tresguerres M, Levin LR, Buck J. Intracellular cAMP signaling by soluble adenylyl cyclase. Kidney Int 79: 1277-1288, 2011.
84. Uawithya P, Pisitkun T, Ruttenberg BE, Knepper MA. Transcriptional profiling of native inner medullary collecting duct cells from rat kidney. Physiol Genomics 32: 229-253, 2008.
85. Veland IR, Awan A, Pedersen LB, Yoder BK, Christensen ST. Primary cilia and signaling pathways in mammalian development, health and disease. Nephron Physiol 111: 39-53, 2009.
86. Wang X, Wu Y, Ward CJ, Harris PC, Torres VE. Vasopressin directly regulates cyst growth in polycystic kidney disease. J Am Soc Nephrol 19: 102-108, 2008.
87. Wang Y, Klein JD, Blount MA, Martin CF, Kent KJ, Pech V, Wall SM, Sands JM. Epac regulates UT-A1 to increase urea transport in inner medullary collecting ducts. J Am Soc Nephrol 20: 2018-2024, 2009.
88. 2+ regulation of adenylyl cyclases in cAMP microdomains. Physiol Rev 87: 965-1010, 2007.
89. Xiao Z, He L, Takemoto M, Jalanko H, Chan GC, Storm DR, Betsholtz C, Tryggvason K, Patrakka J. Glomerular podocytes express type 1 adenylate cyclase: inactivation results in susceptibility to proteinuria. Nephron Exp Nephrol 118: e39-e48, 2011.
90. 2+ mobilization and exocytosis in inner medullary collecting duct. Am J Physiol Renal Physiol 291: F882-F890, 2006.
91. Yoder BK, Mulroy S, Eustace H, Boucher C, Sandford R. Molecular pathogenesis of autosomal dominant polycystic kidney disease. Expert Rev Mol Med 8: 1-22, 2006.